The BioPharm Brief: ADC Expansion, Early Breast Cancer, Biosimilar Momentum

Episode 2  ·  May 18, 08:20 PM
Headliner
Share
Subscribe

Today’s BioPharm Brief covers major developments in antibody-drug conjugates, early-stage HER2-positive breast cancer treatment, and the expanding biosimilars market.

Share
Subscribe
Next
The BioPharm Brief: Smarter Platforms, Safer Therapies, AI Acceleration
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief
The BioPharm Brief: Regulatory Shifts, Rare Disease Innovation, and Precision Drug Development Trends
by The BioPharm Brief